Encompass Health Corporation
EHC
$121.04
-$1.02-0.83%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.68% | 2.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.68% | 2.72% | |||
| Cost of Revenue | 0.45% | 1.94% | |||
| Gross Profit | 0.97% | 3.71% | |||
| SG&A Expenses | 5.31% | -16.78% | |||
| Depreciation & Amortization | 3.55% | 1.04% | |||
| Other Operating Expenses | 5.37% | 9.46% | |||
| Total Operating Expenses | 1.87% | 1.89% | |||
| Operating Income | -4.38% | 6.42% | |||
| Income Before Tax | -9.39% | 12.03% | |||
| Income Tax Expenses | -4.96% | 1.81% | |||
| Earnings from Continuing Operations | -10.46% | 14.83% | |||
| Earnings from Discontinued Operations | -103.77% | 1,887.50% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.37% | 5.79% | |||
| Net Income | -20.87% | 33.13% | |||
| EBIT | -4.38% | 6.42% | |||
| EBITDA | -2.60% | 5.16% | |||
| EPS Basic | -20.56% | 34.49% | |||
| Normalized Basic EPS | -3.00% | 12.53% | |||
| EPS Diluted | -20.40% | 34.98% | |||
| Normalized Diluted EPS | -2.80% | 12.95% | |||
| Average Basic Shares Outstanding | -0.40% | -1.00% | |||
| Average Diluted Shares Outstanding | -0.60% | -1.37% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.18% | -0.20% | |||